MA37530A1 - Composition pharmacologique de la citronnelle (huile essentielle) à effet antibactérien sur d’aggregatibacter actinomycetemcomitans - Google Patents

Composition pharmacologique de la citronnelle (huile essentielle) à effet antibactérien sur d’aggregatibacter actinomycetemcomitans

Info

Publication number
MA37530A1
MA37530A1 MA37530A MA37530A MA37530A1 MA 37530 A1 MA37530 A1 MA 37530A1 MA 37530 A MA37530 A MA 37530A MA 37530 A MA37530 A MA 37530A MA 37530 A1 MA37530 A1 MA 37530A1
Authority
MA
Morocco
Prior art keywords
essential oil
antibacterial effect
citronella
aggregatibacter actinomycetemcomitans
pharmacological composition
Prior art date
Application number
MA37530A
Other languages
English (en)
Other versions
MA37530B1 (fr
Inventor
Leila Lakhdar
Abdellah Farah
Oumkeltoum Ennibi
Original Assignee
Université Mohammed V De Rabat
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Université Mohammed V De Rabat filed Critical Université Mohammed V De Rabat
Priority to MA37530A priority Critical patent/MA37530B1/fr
Priority to PCT/MA2014/000036 priority patent/WO2016076685A1/fr
Publication of MA37530A1 publication Critical patent/MA37530A1/fr
Publication of MA37530B1 publication Critical patent/MA37530B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/121—Ketones acyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Emergency Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

L’application de l’effet antibactérien de l’huile essentielle de citronnelle (cymbopogon citratus) d’origine marocaine sur une souche bactérienne orale virulente ; aggregatibacter actinomycetemcomitans clone jp2. Cette souche originale n’a jamais fait l’objet de tests antimicrobiens à base d’huiles essentielles.Cette nouvelle application englobe aussi bien la méthodologie que les résultats obtenus. La technique utilisée est une méthode simple, claire, basée sur la preuve et offrant une meilleure précision et une meilleure reproductibilité des résultats.
MA37530A 2014-11-13 2014-11-13 Composition pharmacologique de la citronnelle (huile essentielle) à effet antibactérien sur d’aggregatibacter actinomycetemcomitans MA37530B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
MA37530A MA37530B1 (fr) 2014-11-13 2014-11-13 Composition pharmacologique de la citronnelle (huile essentielle) à effet antibactérien sur d’aggregatibacter actinomycetemcomitans
PCT/MA2014/000036 WO2016076685A1 (fr) 2014-11-13 2014-11-27 Composition pharmacologique de la citronnelle (huile essentielle) à effet antibactérien sur aggregatibacter actinomycetemcomitans clone jp2

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MA37530A MA37530B1 (fr) 2014-11-13 2014-11-13 Composition pharmacologique de la citronnelle (huile essentielle) à effet antibactérien sur d’aggregatibacter actinomycetemcomitans

Publications (2)

Publication Number Publication Date
MA37530A1 true MA37530A1 (fr) 2016-06-30
MA37530B1 MA37530B1 (fr) 2017-01-31

Family

ID=52574400

Family Applications (1)

Application Number Title Priority Date Filing Date
MA37530A MA37530B1 (fr) 2014-11-13 2014-11-13 Composition pharmacologique de la citronnelle (huile essentielle) à effet antibactérien sur d’aggregatibacter actinomycetemcomitans

Country Status (2)

Country Link
MA (1) MA37530B1 (fr)
WO (1) WO2016076685A1 (fr)

Also Published As

Publication number Publication date
WO2016076685A1 (fr) 2016-05-19
MA37530B1 (fr) 2017-01-31

Similar Documents

Publication Publication Date Title
CL2020001048A1 (es) Anticuerpos monoclonales contra bcma. (divisional solicitud 201800281)
AR106768A1 (es) Composiciones que comprenden cepas bacterianas
CY1122306T1 (el) Συνθεσεις που περιλαμβανουν bakthpiaka στελεχη
BR112017005762A2 (pt) aprimoramentos na funcionalidade muscular de idosos do sexo masculino
MX2019011496A (es) Composiciones de niraparib.
MX353574B (es) Composiciones con fragancia de liberación prolongada.
CY1124338T1 (el) Αναστολεις 3-φωσφογλυκερικης αφυδρογονασης και χρησεις αυτων
MX2016013067A (es) Dispersion acuosa y composicion de recubrimiento que comprende la misma.
MX369281B (es) Composiciones para el cuidado bucal y metodos para utilizar las composiciones.
NZ725569A (en) Lubricant formulations
AR108546A1 (es) Composiciones, kits y métodos para el control de malezas
MX2019009908A (es) Combinacion de un agonista de ppar con un agonista de fxr.
MX387496B (es) Composiciones tópicas que comprenden pichia anomala y retinol.
BR112017025427A2 (pt) composição farmacêutica oral
BR112021019554A2 (pt) Método de relato, método de configuração, terminal e dispositivo de rede.
MA37534B1 (fr) Composition pharmacologique du thym (huile essentielle) à effet antibactérien sur d’aaggregatibacter actinomycetemcomitans
MA37530A1 (fr) Composition pharmacologique de la citronnelle (huile essentielle) à effet antibactérien sur d’aggregatibacter actinomycetemcomitans
MA37532B1 (fr) Composition pharmacologique de palmarosa (huile essentielle) à effet antibactérien sur d’aaggregatibacter actinomycetemcomitans
MA37533B1 (fr) Composition pharmacologique de l’origan (huile essentielle) à effet antibactérien sur d’aaggregatibacter actinomycetemcomitans
CL2018002949A1 (es) Composiciones para el cuidado bucal.
MA37531A1 (fr) Composition pharmacologique du bigaradier (huile essentielle) à effet antibactérien sur d’aaggregatibacter actinomycetemcomitans
MA37529A1 (fr) Composition pharmacologique de la menthe pouliot (huile essentielle) a effet antibacterien sur l’aggregatibacter actinomycetemcomitans.
CL2020001705A1 (es) Composición acuosa que comprende ácido 2-(dimetil-1h-pirazol-1-il) succínico y amoníaco.
CL2018000568A1 (es) Composición de piensos para la prevención y el tratamiento de infección parasitaria de peces
AU2015205151A1 (en) 5-hydroxy-1H-imidazole-4-carboxamide effective-dose/sensitivity prediction method and prediction device, xanthosine-monophosphate-amount measurement method, and myelodysplastic-syndrome treatment agent and treatment method